nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Sevoflurane—CYP3A4—breast cancer	0.00258	0.534	CrCbGaD
Perflutren—Sevoflurane—ALB—breast cancer	0.00225	0.466	CrCbGaD
Perflutren—Vomiting—Mitoxantrone—breast cancer	0.000253	0.000254	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—breast cancer	0.000252	0.000254	CcSEcCtD
Perflutren—Dizziness—Fluorouracil—breast cancer	0.000252	0.000253	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—breast cancer	0.000252	0.000253	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—breast cancer	0.000252	0.000253	CcSEcCtD
Perflutren—Rash—Mitoxantrone—breast cancer	0.000251	0.000252	CcSEcCtD
Perflutren—Rash—Irinotecan—breast cancer	0.000251	0.000252	CcSEcCtD
Perflutren—Dermatitis—Mitoxantrone—breast cancer	0.000251	0.000252	CcSEcCtD
Perflutren—Dermatitis—Irinotecan—breast cancer	0.000251	0.000252	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000251	0.000252	CcSEcCtD
Perflutren—Chills—Methotrexate—breast cancer	0.000251	0.000252	CcSEcCtD
Perflutren—Headache—Mitoxantrone—breast cancer	0.00025	0.000251	CcSEcCtD
Perflutren—Headache—Irinotecan—breast cancer	0.00025	0.000251	CcSEcCtD
Perflutren—Hypotension—Capecitabine—breast cancer	0.000249	0.00025	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—breast cancer	0.000247	0.000248	CcSEcCtD
Perflutren—Vomiting—Gemcitabine—breast cancer	0.000247	0.000248	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—breast cancer	0.000246	0.000247	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—breast cancer	0.000245	0.000247	CcSEcCtD
Perflutren—Rash—Gemcitabine—breast cancer	0.000245	0.000246	CcSEcCtD
Perflutren—Dermatitis—Gemcitabine—breast cancer	0.000244	0.000246	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—breast cancer	0.000244	0.000245	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—breast cancer	0.000244	0.000245	CcSEcCtD
Perflutren—Erythema—Methotrexate—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Headache—Gemcitabine—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Flushing—Epirubicin—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Vomiting—Fluorouracil—breast cancer	0.000243	0.000244	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—breast cancer	0.000242	0.000244	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—breast cancer	0.000242	0.000244	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—breast cancer	0.000242	0.000243	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—breast cancer	0.000241	0.000242	CcSEcCtD
Perflutren—Rash—Fluorouracil—breast cancer	0.000241	0.000242	CcSEcCtD
Perflutren—Dermatitis—Fluorouracil—breast cancer	0.00024	0.000241	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—breast cancer	0.00024	0.000241	CcSEcCtD
Perflutren—Paraesthesia—Capecitabine—breast cancer	0.000239	0.000241	CcSEcCtD
Perflutren—Hypersensitivity—Paclitaxel—breast cancer	0.000239	0.00024	CcSEcCtD
Perflutren—Headache—Fluorouracil—breast cancer	0.000239	0.00024	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—breast cancer	0.000238	0.000239	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—breast cancer	0.000238	0.000239	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—breast cancer	0.000238	0.000239	CcSEcCtD
Perflutren—Dyspnoea—Capecitabine—breast cancer	0.000238	0.000239	CcSEcCtD
Perflutren—Fatigue—Docetaxel—breast cancer	0.000237	0.000239	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—breast cancer	0.000237	0.000238	CcSEcCtD
Perflutren—Nausea—Mitoxantrone—breast cancer	0.000237	0.000238	CcSEcCtD
Perflutren—Nausea—Irinotecan—breast cancer	0.000237	0.000238	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—breast cancer	0.000236	0.000237	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—breast cancer	0.000236	0.000237	CcSEcCtD
Perflutren—Pain—Docetaxel—breast cancer	0.000235	0.000237	CcSEcCtD
Perflutren—Back pain—Methotrexate—breast cancer	0.000235	0.000236	CcSEcCtD
Perflutren—Dyspepsia—Capecitabine—breast cancer	0.000235	0.000236	CcSEcCtD
Perflutren—Chills—Epirubicin—breast cancer	0.000235	0.000236	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—breast cancer	0.000234	0.000235	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—breast cancer	0.000233	0.000234	CcSEcCtD
Perflutren—Asthenia—Paclitaxel—breast cancer	0.000233	0.000234	CcSEcCtD
Perflutren—Nausea—Gemcitabine—breast cancer	0.00023	0.000232	CcSEcCtD
Perflutren—Gastrointestinal disorder—Capecitabine—breast cancer	0.00023	0.000231	CcSEcCtD
Perflutren—Fatigue—Capecitabine—breast cancer	0.00023	0.000231	CcSEcCtD
Perflutren—Pruritus—Paclitaxel—breast cancer	0.00023	0.000231	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—breast cancer	0.000229	0.00023	CcSEcCtD
Perflutren—Pain—Capecitabine—breast cancer	0.000228	0.000229	CcSEcCtD
Perflutren—Erythema—Epirubicin—breast cancer	0.000228	0.000229	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—breast cancer	0.000227	0.000228	CcSEcCtD
Perflutren—Nausea—Fluorouracil—breast cancer	0.000227	0.000228	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—breast cancer	0.000226	0.000227	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—breast cancer	0.000226	0.000227	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—breast cancer	0.000226	0.000227	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—breast cancer	0.000225	0.000226	CcSEcCtD
Perflutren—Flushing—Doxorubicin—breast cancer	0.000224	0.000226	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—breast cancer	0.000224	0.000226	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—breast cancer	0.000223	0.000224	CcSEcCtD
Perflutren—Diarrhoea—Paclitaxel—breast cancer	0.000222	0.000223	CcSEcCtD
Perflutren—Back pain—Epirubicin—breast cancer	0.00022	0.000221	CcSEcCtD
Perflutren—Feeling abnormal—Capecitabine—breast cancer	0.00022	0.000221	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—breast cancer	0.000219	0.000221	CcSEcCtD
Perflutren—Malaise—Methotrexate—breast cancer	0.000219	0.00022	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—breast cancer	0.000219	0.00022	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—breast cancer	0.000218	0.00022	CcSEcCtD
Perflutren—Vertigo—Methotrexate—breast cancer	0.000218	0.00022	CcSEcCtD
Perflutren—Gastrointestinal pain—Capecitabine—breast cancer	0.000218	0.000219	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—breast cancer	0.000218	0.000219	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—breast cancer	0.000218	0.000219	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—breast cancer	0.000218	0.000219	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—breast cancer	0.000218	0.000219	CcSEcCtD
Perflutren—Chills—Doxorubicin—breast cancer	0.000217	0.000218	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—breast cancer	0.000216	0.000217	CcSEcCtD
Perflutren—Dizziness—Paclitaxel—breast cancer	0.000215	0.000216	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—breast cancer	0.000214	0.000215	CcSEcCtD
Perflutren—Cough—Methotrexate—breast cancer	0.000212	0.000213	CcSEcCtD
Perflutren—Urticaria—Capecitabine—breast cancer	0.000212	0.000213	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—breast cancer	0.000211	0.000212	CcSEcCtD
Perflutren—Abdominal pain—Capecitabine—breast cancer	0.000211	0.000212	CcSEcCtD
Perflutren—Body temperature increased—Capecitabine—breast cancer	0.000211	0.000212	CcSEcCtD
Perflutren—Convulsion—Methotrexate—breast cancer	0.000211	0.000212	CcSEcCtD
Perflutren—Erythema—Doxorubicin—breast cancer	0.000211	0.000212	CcSEcCtD
Perflutren—Agitation—Epirubicin—breast cancer	0.000209	0.00021	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—breast cancer	0.000207	0.000208	CcSEcCtD
Perflutren—Chest pain—Methotrexate—breast cancer	0.000207	0.000208	CcSEcCtD
Perflutren—Myalgia—Methotrexate—breast cancer	0.000207	0.000208	CcSEcCtD
Perflutren—Vomiting—Paclitaxel—breast cancer	0.000207	0.000208	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—breast cancer	0.000206	0.000207	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000206	0.000207	CcSEcCtD
Perflutren—Malaise—Epirubicin—breast cancer	0.000205	0.000206	CcSEcCtD
Perflutren—Rash—Paclitaxel—breast cancer	0.000205	0.000206	CcSEcCtD
Perflutren—Dermatitis—Paclitaxel—breast cancer	0.000205	0.000206	CcSEcCtD
Perflutren—Discomfort—Methotrexate—breast cancer	0.000205	0.000206	CcSEcCtD
Perflutren—Vertigo—Epirubicin—breast cancer	0.000204	0.000205	CcSEcCtD
Perflutren—Syncope—Epirubicin—breast cancer	0.000204	0.000205	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—breast cancer	0.000204	0.000205	CcSEcCtD
Perflutren—Back pain—Doxorubicin—breast cancer	0.000204	0.000205	CcSEcCtD
Perflutren—Headache—Paclitaxel—breast cancer	0.000204	0.000204	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—breast cancer	0.000203	0.000204	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—breast cancer	0.000202	0.000203	CcSEcCtD
Perflutren—Palpitations—Epirubicin—breast cancer	0.000201	0.000202	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—breast cancer	0.0002	0.000201	CcSEcCtD
Perflutren—Cough—Epirubicin—breast cancer	0.000199	0.0002	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—breast cancer	0.000198	0.000199	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—breast cancer	0.000198	0.000199	CcSEcCtD
Perflutren—Asthenia—Docetaxel—breast cancer	0.000198	0.000199	CcSEcCtD
Perflutren—Convulsion—Epirubicin—breast cancer	0.000197	0.000198	CcSEcCtD
Perflutren—Hypertension—Epirubicin—breast cancer	0.000196	0.000197	CcSEcCtD
Perflutren—Hypersensitivity—Capecitabine—breast cancer	0.000196	0.000197	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—breast cancer	0.000195	0.000196	CcSEcCtD
Perflutren—Pruritus—Docetaxel—breast cancer	0.000195	0.000196	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—breast cancer	0.000195	0.000196	CcSEcCtD
Perflutren—Chest pain—Epirubicin—breast cancer	0.000194	0.000195	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—breast cancer	0.000194	0.000195	CcSEcCtD
Perflutren—Myalgia—Epirubicin—breast cancer	0.000194	0.000195	CcSEcCtD
Perflutren—Agitation—Doxorubicin—breast cancer	0.000193	0.000194	CcSEcCtD
Perflutren—Nausea—Paclitaxel—breast cancer	0.000193	0.000194	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—breast cancer	0.000193	0.000194	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000192	0.000193	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—breast cancer	0.000192	0.000193	CcSEcCtD
Perflutren—Discomfort—Epirubicin—breast cancer	0.000191	0.000192	CcSEcCtD
Perflutren—Asthenia—Capecitabine—breast cancer	0.000191	0.000192	CcSEcCtD
Perflutren—Malaise—Doxorubicin—breast cancer	0.00019	0.000191	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—breast cancer	0.000189	0.00019	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—breast cancer	0.000189	0.00019	CcSEcCtD
Perflutren—Syncope—Doxorubicin—breast cancer	0.000189	0.00019	CcSEcCtD
Perflutren—Pruritus—Capecitabine—breast cancer	0.000189	0.00019	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—breast cancer	0.000188	0.000189	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—breast cancer	0.000188	0.000189	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—breast cancer	0.000186	0.000187	CcSEcCtD
Perflutren—Oedema—Epirubicin—breast cancer	0.000186	0.000187	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—breast cancer	0.000186	0.000187	CcSEcCtD
Perflutren—Hypotension—Methotrexate—breast cancer	0.000185	0.000186	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—breast cancer	0.000185	0.000186	CcSEcCtD
Perflutren—Cough—Doxorubicin—breast cancer	0.000184	0.000185	CcSEcCtD
Perflutren—Shock—Epirubicin—breast cancer	0.000183	0.000184	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—breast cancer	0.000182	0.000183	CcSEcCtD
Perflutren—Diarrhoea—Capecitabine—breast cancer	0.000182	0.000183	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—breast cancer	0.000182	0.000183	CcSEcCtD
Perflutren—Dizziness—Docetaxel—breast cancer	0.000182	0.000183	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—breast cancer	0.000182	0.000183	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—breast cancer	0.000181	0.000182	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000181	0.000182	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—breast cancer	0.00018	0.000181	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—breast cancer	0.00018	0.00018	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—breast cancer	0.000179	0.00018	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—breast cancer	0.000179	0.00018	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—breast cancer	0.000179	0.00018	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—breast cancer	0.000178	0.000179	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000178	0.000179	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—breast cancer	0.000177	0.000178	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—breast cancer	0.000177	0.000178	CcSEcCtD
Perflutren—Dizziness—Capecitabine—breast cancer	0.000176	0.000177	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—breast cancer	0.000175	0.000176	CcSEcCtD
Perflutren—Vomiting—Docetaxel—breast cancer	0.000175	0.000176	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—breast cancer	0.000175	0.000176	CcSEcCtD
Perflutren—Rash—Docetaxel—breast cancer	0.000174	0.000174	CcSEcCtD
Perflutren—Hypotension—Epirubicin—breast cancer	0.000174	0.000174	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—breast cancer	0.000173	0.000174	CcSEcCtD
Perflutren—Headache—Docetaxel—breast cancer	0.000172	0.000173	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—breast cancer	0.000172	0.000173	CcSEcCtD
Perflutren—Oedema—Doxorubicin—breast cancer	0.000172	0.000173	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—breast cancer	0.000171	0.000172	CcSEcCtD
Perflutren—Fatigue—Methotrexate—breast cancer	0.000171	0.000172	CcSEcCtD
Perflutren—Pain—Methotrexate—breast cancer	0.00017	0.000171	CcSEcCtD
Perflutren—Vomiting—Capecitabine—breast cancer	0.000169	0.00017	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000169	0.00017	CcSEcCtD
Perflutren—Shock—Doxorubicin—breast cancer	0.000169	0.00017	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—breast cancer	0.000169	0.000169	CcSEcCtD
Perflutren—Rash—Capecitabine—breast cancer	0.000168	0.000169	CcSEcCtD
Perflutren—Dermatitis—Capecitabine—breast cancer	0.000168	0.000169	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—breast cancer	0.000168	0.000169	CcSEcCtD
Perflutren—Headache—Capecitabine—breast cancer	0.000167	0.000168	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—breast cancer	0.000167	0.000168	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—breast cancer	0.000167	0.000168	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—breast cancer	0.000166	0.000167	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—breast cancer	0.000166	0.000166	CcSEcCtD
Perflutren—Nausea—Docetaxel—breast cancer	0.000164	0.000164	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—breast cancer	0.000164	0.000164	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—breast cancer	0.000163	0.000164	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—breast cancer	0.000162	0.000163	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—breast cancer	0.00016	0.000161	CcSEcCtD
Perflutren—Fatigue—Epirubicin—breast cancer	0.00016	0.000161	CcSEcCtD
Perflutren—Pain—Epirubicin—breast cancer	0.000159	0.00016	CcSEcCtD
Perflutren—Nausea—Capecitabine—breast cancer	0.000158	0.000159	CcSEcCtD
Perflutren—Urticaria—Methotrexate—breast cancer	0.000158	0.000158	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—breast cancer	0.000157	0.000158	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—breast cancer	0.000157	0.000158	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000157	0.000157	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—breast cancer	0.000154	0.000155	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—breast cancer	0.000153	0.000154	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—breast cancer	0.000153	0.000154	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—breast cancer	0.000152	0.000153	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—breast cancer	0.000151	0.000152	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000148	0.000149	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—breast cancer	0.000148	0.000149	CcSEcCtD
Perflutren—Urticaria—Epirubicin—breast cancer	0.000148	0.000148	CcSEcCtD
Perflutren—Pain—Doxorubicin—breast cancer	0.000147	0.000148	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—breast cancer	0.000147	0.000148	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—breast cancer	0.000147	0.000148	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—breast cancer	0.000146	0.000147	CcSEcCtD
Perflutren—Asthenia—Methotrexate—breast cancer	0.000142	0.000143	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—breast cancer	0.000142	0.000142	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—breast cancer	0.000141	0.000141	CcSEcCtD
Perflutren—Pruritus—Methotrexate—breast cancer	0.00014	0.000141	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—breast cancer	0.000137	0.000137	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—breast cancer	0.000137	0.000137	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—breast cancer	0.000136	0.000137	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—breast cancer	0.000136	0.000137	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—breast cancer	0.000136	0.000136	CcSEcCtD
Perflutren—Asthenia—Epirubicin—breast cancer	0.000133	0.000134	CcSEcCtD
Perflutren—Pruritus—Epirubicin—breast cancer	0.000131	0.000132	CcSEcCtD
Perflutren—Dizziness—Methotrexate—breast cancer	0.000131	0.000132	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—breast cancer	0.000127	0.000128	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—breast cancer	0.000127	0.000127	CcSEcCtD
Perflutren—Vomiting—Methotrexate—breast cancer	0.000126	0.000127	CcSEcCtD
Perflutren—Rash—Methotrexate—breast cancer	0.000125	0.000126	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—breast cancer	0.000125	0.000126	CcSEcCtD
Perflutren—Headache—Methotrexate—breast cancer	0.000124	0.000125	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—breast cancer	0.000123	0.000124	CcSEcCtD
Perflutren—Dizziness—Epirubicin—breast cancer	0.000123	0.000123	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—breast cancer	0.000122	0.000122	CcSEcCtD
Perflutren—Vomiting—Epirubicin—breast cancer	0.000118	0.000119	CcSEcCtD
Perflutren—Nausea—Methotrexate—breast cancer	0.000118	0.000118	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—breast cancer	0.000118	0.000118	CcSEcCtD
Perflutren—Rash—Epirubicin—breast cancer	0.000117	0.000118	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—breast cancer	0.000117	0.000118	CcSEcCtD
Perflutren—Headache—Epirubicin—breast cancer	0.000116	0.000117	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—breast cancer	0.000114	0.000114	CcSEcCtD
Perflutren—Nausea—Epirubicin—breast cancer	0.00011	0.000111	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—breast cancer	0.000109	0.00011	CcSEcCtD
Perflutren—Rash—Doxorubicin—breast cancer	0.000108	0.000109	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—breast cancer	0.000108	0.000109	CcSEcCtD
Perflutren—Headache—Doxorubicin—breast cancer	0.000108	0.000108	CcSEcCtD
Perflutren—Nausea—Doxorubicin—breast cancer	0.000102	0.000103	CcSEcCtD
